174 related articles for article (PubMed ID: 29720484)
1. Ubiquitin-dependent degradation of CDK2 drives the therapeutic differentiation of AML by targeting PRDX2.
Ying M; Shao X; Jing H; Liu Y; Qi X; Cao J; Chen Y; Xiang S; Song H; Hu R; Wei G; Yang B; He Q
Blood; 2018 Jun; 131(24):2698-2711. PubMed ID: 29720484
[TBL] [Abstract][Full Text] [Related]
2. CDK2-instigates C/EBPα degradation through SKP2 in Acute myeloid leukemia.
Thacker G; Mishra M; Sharma A; Singh AK; Sanyal S; Trivedi AK
Med Oncol; 2021 May; 38(6):69. PubMed ID: 34002296
[TBL] [Abstract][Full Text] [Related]
3. Icariside II induces cell cycle arrest and differentiation via TLR8/MyD88/p38 pathway in acute myeloid leukemia cells.
Yang J; Lan J; Du H; Zhang X; Li A; Zhang X; Liu Y; Zhang J; Zhang C; Ding Y; Zhang T
Eur J Pharmacol; 2019 Mar; 846():12-22. PubMed ID: 30579933
[TBL] [Abstract][Full Text] [Related]
4. CDK2 destabilizes tumor suppressor C/EBPα expression through ubiquitin-mediated proteasome degradation in acute myeloid leukemia.
Thacker G; Mishra M; Sharma A; Singh AK; Sanyal S; Trivedi AK
J Cell Biochem; 2020 Apr; 121(4):2839-2850. PubMed ID: 31692040
[TBL] [Abstract][Full Text] [Related]
5. miR-638 regulates differentiation and proliferation in leukemic cells by targeting cyclin-dependent kinase 2.
Lin Y; Li D; Liang Q; Liu S; Zuo X; Li L; Sun X; Li W; Guo M; Huang Z
J Biol Chem; 2015 Jan; 290(3):1818-28. PubMed ID: 25451924
[TBL] [Abstract][Full Text] [Related]
6. CDK2 suppression synergizes with all-trans-retinoic acid to overcome the myeloid differentiation blockade of AML cells.
Shao X; Xiang S; Fu H; Chen Y; Xu A; Liu Y; Qi X; Cao J; Zhu H; Yang B; He Q; Ying M
Pharmacol Res; 2020 Jan; 151():104545. PubMed ID: 31740384
[TBL] [Abstract][Full Text] [Related]
7. Discovery of a first-in-class CDK2 selective degrader for AML differentiation therapy.
Wang L; Shao X; Zhong T; Wu Y; Xu A; Sun X; Gao H; Liu Y; Lan T; Tong Y; Tao X; Du W; Wang W; Chen Y; Li T; Meng X; Deng H; Yang B; He Q; Ying M; Rao Y
Nat Chem Biol; 2021 May; 17(5):567-575. PubMed ID: 33664520
[TBL] [Abstract][Full Text] [Related]
8. Ring finger protein 138 inhibits transcription factor C/EBPα protein turnover leading to differentiation arrest in acute myeloid leukemia.
Singh AK; Upadhyay V; Sethi A; Chowdhury S; Mishra S; Verma SP; Bhatt MLB; Trivedi AK
Biochem J; 2024 May; 481(10):653-666. PubMed ID: 38666590
[TBL] [Abstract][Full Text] [Related]
9. E3 ubiquitin ligase Fbw7 negatively regulates granulocytic differentiation by targeting G-CSFR for degradation.
Lochab S; Pal P; Kapoor I; Kanaujiya JK; Sanyal S; Behre G; Trivedi AK
Biochim Biophys Acta; 2013 Dec; 1833(12):2639-2652. PubMed ID: 23820376
[TBL] [Abstract][Full Text] [Related]
10. The ubiquitin-proteasome pathway plays essential roles in ATRA-induced leukemia cells G0/G1 phase arrest and transition into granulocytic differentiation.
Fang Y; Zhou X; Lin M; Jing H; Zhong L; Ying M; Luo P; Yang B; He Q
Cancer Biol Ther; 2010 Dec; 10(11):1157-67. PubMed ID: 20935519
[TBL] [Abstract][Full Text] [Related]
11. CDK Family PROTAC Profiling Reveals Distinct Kinetic Responses and Cell Cycle-Dependent Degradation of CDK2.
Riching KM; Schwinn MK; Vasta JD; Robers MB; Machleidt T; Urh M; Daniels DL
SLAS Discov; 2021 Apr; 26(4):560-569. PubMed ID: 33190579
[TBL] [Abstract][Full Text] [Related]
12. E3 ligase SCF
Thacker G; Mishra M; Sharma A; Singh AK; Sanyal S; Trivedi AK
Life Sci; 2020 Sep; 257():118041. PubMed ID: 32622945
[TBL] [Abstract][Full Text] [Related]
13. MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets.
Su R; Lin HS; Zhang XH; Yin XL; Ning HM; Liu B; Zhai PF; Gong JN; Shen C; Song L; Chen J; Wang F; Zhao HL; Ma YN; Yu J; Zhang JW
Oncogene; 2015 Jun; 34(25):3226-39. PubMed ID: 25174404
[TBL] [Abstract][Full Text] [Related]
14. TRIB3 destabilizes tumor suppressor PPARα expression through ubiquitin-mediated proteasome degradation in acute myeloid leukemia.
Luo X; Zhong L; Yu L; Xiong L; Dan W; Li J; Ye J; Chu X; Liu C; Liu B
Life Sci; 2020 Sep; 257():118021. PubMed ID: 32621919
[TBL] [Abstract][Full Text] [Related]
15. The E3 ubiquitin ligase WWP1 sustains the growth of acute myeloid leukaemia.
Sanarico AG; Ronchini C; Croce A; Memmi EM; Cammarata UA; De Antoni A; Lavorgna S; Divona M; Giacò L; Melloni GEM; Brendolan A; Simonetti G; Martinelli G; Mancuso P; Bertolini F; Coco FL; Melino G; Pelicci PG; Bernassola F
Leukemia; 2018 Apr; 32(4):911-919. PubMed ID: 29209041
[TBL] [Abstract][Full Text] [Related]
16. Compound kushen injection suppresses human acute myeloid leukaemia by regulating the Prdxs/ROS/Trx1 signalling pathway.
Jin Y; Yang Q; Liang L; Ding L; Liang Y; Zhang D; Wu B; Yang T; Liu H; Huang T; Shen H; Tu H; Pan Y; Wei Y; Yang Y; Zhou F
J Exp Clin Cancer Res; 2018 Nov; 37(1):277. PubMed ID: 30454068
[TBL] [Abstract][Full Text] [Related]
17. Expression and regulation of G1 cell-cycle inhibitors (p16INK4A, p15INK4B, p18INK4C, p19INK4D) in human acute myeloid leukemia and normal myeloid cells.
Schwaller J; Pabst T; Koeffler HP; Niklaus G; Loetscher P; Fey MF; Tobler A
Leukemia; 1997 Jan; 11(1):54-63. PubMed ID: 9001419
[TBL] [Abstract][Full Text] [Related]
18. Isocitrate dehydrogenase 1 mutations prime the all-trans retinoic acid myeloid differentiation pathway in acute myeloid leukemia.
Boutzen H; Saland E; Larrue C; de Toni F; Gales L; Castelli FA; Cathebas M; Zaghdoudi S; Stuani L; Kaoma T; Riscal R; Yang G; Hirsch P; David M; De Mas-Mansat V; Delabesse E; Vallar L; Delhommeau F; Jouanin I; Ouerfelli O; Le Cam L; Linares LK; Junot C; Portais JC; Vergez F; Récher C; Sarry JE
J Exp Med; 2016 Apr; 213(4):483-97. PubMed ID: 26951332
[TBL] [Abstract][Full Text] [Related]
19. p62/SQSTM1 upregulation constitutes a survival mechanism that occurs during granulocytic differentiation of acute myeloid leukemia cells.
Trocoli A; Bensadoun P; Richard E; Labrunie G; Merhi F; Schläfli AM; Brigger D; Souquere S; Pierron G; Pasquet JM; Soubeyran P; Reiffers J; Ségal-Bendirdjian E; Tschan MP; Djavaheri-Mergny M
Cell Death Differ; 2014 Dec; 21(12):1852-61. PubMed ID: 25034783
[TBL] [Abstract][Full Text] [Related]
20. Combination of celecoxib and doxorubicin increases growth inhibition and apoptosis in acute myeloid leukemia cells.
Chen C; Xu W; Wang CM
Leuk Lymphoma; 2013 Nov; 54(11):2517-22. PubMed ID: 23452119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
